Cardiac Autonomic Dysfunction Is Associated With High-Risk Albumin-to-Creatinine Ratio in Young Adolescents With Type 1 Diabetes in AdDIT (Adolescent Type 1 Diabetes Cardio-Renal Interventional Trial)

Pathophysiology/Complications

Yoon Hi Cho¹,²,
Maria E. Craig¹,²,³,
Elizabeth A. Davis⁴,⁵,
Andrew M. Cotterill⁶,
Jennifer J. Couper⁷,
Fergus J. Cameron⁸,⁹,¹⁰,
Paul Z. Benitez-Aguirre¹,²,
R. Neil Dalton¹¹,
David B. Dunger¹²,
Timothy W. Jones⁴,⁵ and
Kim C. Donaghue¹,² ⇑
on behalf of the Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)*

¹Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia
²Discipline of Paediatrics and Child Health, The University of Sydney, Sydney, New South Wales, Australia
³School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia
⁴Department of Endocrinology and Diabetes, Princess Margaret Hospital for Children, Perth, Western Australia, Australia
⁵Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia
⁶Department of Paediatric Endocrinology, Mater Children's Hospital, Brisbane, Queensland, Australia
⁷Endocrinology and Diabetes Centre, Women's and Children's Hospital, and Robinson Institute, University of Adelaide, Adelaide, South Australia, Australia
⁸Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Victoria, Australia
⁹Murdoch Children’s Research Institute, Melbourne, Victoria, Australia
¹⁰The University of Melbourne, Melbourne, Victoria, Australia
¹¹WellChild Laboratory, St Thomas' Hospital, London, U.K.
¹²University Department of Paediatrics, Addenbrooke's Hospital, Cambridge, U.K.

Diabetes Care 2015 Apr; 38(4): 676-681. https://doi.org/10.2337/dc14-1848

Article Information

vol. 38 no. 4 676-681

DOI

PubMed

Published By

Print ISSN

Online ISSN

History

Yoon Hi Cho¹,²,
Maria E. Craig¹,²,³,
Elizabeth A. Davis⁴,⁵,
Andrew M. Cotterill⁶,
Jennifer J. Couper⁷,
Fergus J. Cameron⁸,⁹,¹⁰,
Paul Z. Benitez-Aguirre¹,²,
R. Neil Dalton¹¹,
David B. Dunger¹²,
Timothy W. Jones⁴,⁵ and
Kim C. Donaghue¹,² ⇑
on behalf of the Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)*

¹Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia
²Discipline of Paediatrics and Child Health, The University of Sydney, Sydney, New South Wales, Australia
³School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia
⁴Department of Endocrinology and Diabetes, Princess Margaret Hospital for Children, Perth, Western Australia, Australia
⁵Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia
⁶Department of Paediatric Endocrinology, Mater Children's Hospital, Brisbane, Queensland, Australia
⁷Endocrinology and Diabetes Centre, Women's and Children's Hospital, and Robinson Institute, University of Adelaide, Adelaide, South Australia, Australia
⁸Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Victoria, Australia
⁹Murdoch Children’s Research Institute, Melbourne, Victoria, Australia
¹⁰The University of Melbourne, Melbourne, Victoria, Australia
¹¹WellChild Laboratory, St Thomas' Hospital, London, U.K.
¹²University Department of Paediatrics, Addenbrooke's Hospital, Cambridge, U.K.

Rendering graph...